SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-21-000069
Filing Date
2021-10-27
Accepted
2021-10-27 07:20:15
Documents
12
Period of Report
2021-10-27
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20211027.htm   iXBRL 8-K 40837
  Complete submission text file 0001280600-21-000069.txt   177566

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20211027.xsd EX-101.SCH 1936
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20211027_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20211027_pre.xml EX-101.PRE 12534
5 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20211027_htm.xml XML 11367
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 211350687
SIC: 2836 Biological Products, (No Diagnostic Substances)